Recent Articles

• SCYNEXIS Inc. Delivers Promising Updates and Financial Insights
• Aptose's Promising Insights: Q2 2025 Financial Overview
• Opus Genetics Unveils Q2 2025 Financial Achievements and Updates
• Contango ORE Reports Significant Growth in Quarterly Earnings
• Celebrating the 2025 Eric Dostie Memorial Scholarship Winners
• FiEE Reports Major Financial Shifts for Fiscal Half-Year 2025
• Planet 13 Holdings Inc. Reports Q2 2025 Financial Outcomes
• KBR Secures $2.459 Billion Contract to Enhance Astronaut Health
• Aptose Biosciences Achieves Promising Progress in AML Treatment
• Global Water Resources Reports Promising Q2 2025 Earnings Results
• Drilling Tools International Corp. Reports Solid Q2 2025 Results
• Opus Genetics Unveils Promising Q2 2025 Financial Results
• Gap Inc. Declares Dividend Amid Strategic Growth Initiatives
• Strategic Partnership Emerges: OrthoNY Collaborates with Zenyth
• Financial Insights and Updates from SCYNEXIS for 2025
• Empowering Young Minds: Usha Vance's Literacy Initiative
• Julie A. Beck Takes Charge as CFO at MSA Safety Incorporated
• Planet 13's Q2 Financial Report: Navigating Challenges Ahead
• Contango Reports Record Income and Projections for 2025
• XWELL, Inc. Prepares to Share Second Quarter Results Soon
• FiEE, Inc. Reveals Positive Trends in Financial Performance
• Global Water Resources Reports Q2 2025 Performance Insights
• MDU Resources Welcomes New Board Members for Enhanced Growth
• B. Riley Financial Reports Strong Momentum for 2025
• Preparations for the 2026 Presidents Cup Begin in Chicago
• 60 Degrees Pharmaceuticals Reveals Q2 Performance Updates
• Alvotech Celebrates Remarkable Growth Amid Strategic Expansion
• Alvotech: A Milestone Half-Year Overview and Future Outlook
• CaliberCos Inc. Shares Insights on Q2 2025 Financials
• Faraday Future Prepares for Major Updates and Earnings Call
• Dillard's, Inc. to Announce Financial Results for Second Quarter
• KBR Secures $2.459 Billion NASA Contract for Astronaut Support
• Leadership Transitions at Royalty Pharma: Henry Fernandez Steps Down
• Kelso Technologies Announces Leadership Transition with New Director
• Dillard's, Inc. Set to Reveal Key Financial Performance Indicators
• Kelso Technologies Welcomes New Leadership Amid Director Change
• Faraday Future Prepares for Major Strategy Announcement Soon
• Innovative Advances and Financial Overview from Acrivon Therapeutics
• Leadership Transition at Royalty Pharma: Henry Fernandez Steps Down
• FIGX Capital Unveils Separate Trading of Shares and Warrants
• Remarkable Returns: The Growth of Synopsys Stock Over 15 Years
• Orezone Gold Unveils Strong Q2 2025 Performance Metrics
• Block Inc Seeks $1.5 Billion Through New Debt Offering
• Crescent Capital BDC's Earnings Reveal Growth and Stability
• Investigation of PubMatic, Inc.: Key Insights for Investors
• Vivani Medical Advances Semaglutide Implant Development with Funding
• Legal Action for KinderCare Investors Facing Losses Initiated
• New Affordable Rental Housing Initiative Announced by Canada
• Century Communities Reveals Quarterly Cash Dividend Plans
• Incoco Capital and Partners Announce Exciting Skyscraper Project